Core Scientific, Inc. (CORZ) stock plummeted 6.01% in pre-market trading on Thursday, extending losses from the previous session.
The sharp decline followed the company's release of first-quarter fiscal 2026 financial results, which showed a wider-than-expected loss. Core Scientific reported a net loss of $347.2 million, or $1.06 per diluted share, significantly missing the FactSet consensus estimate of a $0.06 loss. The results included $266.5 million in non-cash impairment charges, representing a sharp swing from profitability in the year-ago period.
Additional negative pressure came from regulatory filings showing insider stock sales by the company's Chief Legal Officer just days before the earnings release, which may have contributed to the bearish sentiment among investors.
Comments